Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myt Netherlands Parent B.V. ADR (NY: MYTE )

7.490 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5
Open 7.490
Bid (Size) 7.070 (2)
Ask (Size) 8.000 (1)
Prev. Close 7.490
Today's Range 7.490 - 7.490
52wk Range 2.050 - 8.242
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Via Benzinga

Performance

YTD
+130.46%
+130.46%
1 Month
+93.04%
+93.04%
3 Month
+73.38%
+73.38%
6 Month
+98.67%
+98.67%
1 Year
+131.89%
+131.89%

More News

Read More
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Via Benzinga
What's Going On With MYT Netherlands Shares Monday?
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
Earnings Outlook For MYT Netherlands Parent
Via Benzinga
MYT Netherlands Parent B.V. (“Mytheresa”) and Richemont sign agreement for Mytheresa to acquire YOOX NET-A-PORTER (“YNAP”) to create leading, global, multi-brand digital luxury group in exchange for a 33% equity stake in Mytheresa
From MYT Netherlands Parent B.V.
Via Business Wire
Strong Full FY24 results for Mytheresa driven by +14% Net Sales growth in H2 compared to last year and continued profitability with 4% Adj. EBITDA margin in H2 FY24
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Fourth Quarter and Full Fiscal Year 2024 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mytheresa to Participate in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
MYTE Stock Earnings: MYT Netherlands Parent Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Q3 FY24 Results: Mytheresa Posts +18% Net Sales Growth and a Significantly Improved Adjusted EBITDA Margin Compared to the Previous Year Quarter
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Preliminary Third Quarter Results – Double-Digit Topline Growth Significantly Improved Profitability
From MYT Netherlands Parent B.V.
Via Business Wire
A Preview Of MYT Netherlands Parent's Earnings
Via Benzinga
Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Q2 FY24 Results: Mytheresa posts positive growth and strong financial results outperforming a consolidating market
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Second Quarter of Fiscal Year 2024 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Q1 FY24 Results: Mytheresa Grows +7% in Net Sales in the First Quarter
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Scheduled For November 28, 2023
Via Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.